Founder & CEO · Mantis Biotech · New York, New York, United States
Fresh capital means vendor and tool decisions are happening right now.
Open roles signal budget is being allocated across the org.
Most founders lock in key vendors within 60 days of closing a round.
Mantis builds the infrastructure layer for living, predictive models of individual human beings — forecast to the horizon where a decision still has to be made. Starting with medicine.
